Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Apr;55(4):266-70.
doi: 10.1136/jcp.55.4.266.

Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency)

Affiliations
Review

Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency)

A Fay et al. J Clin Pathol. 2002 Apr.

Abstract

Hereditary angio-oedema is characterised by recurrent swellings in any part of the body and also by recurrent attacks of severe abdominal pain. The disease is inherited in an autosomal dominant manner but up to 25% of cases can occur as a spontaneous mutation. Attacks of swelling can be precipitated by trauma, certain drugs, and emotional stress. Treatment usually involves a combination of prophylaxis, using androgens or antifibrolytic drugs, and replacement with C'1 esterase inhibitor concentrate for acute attacks and before surgery or other traumatic procedures.

PubMed Disclaimer

References

    1. Tosi M. Molecular genetics of C`1-inhibitor. Immunobiology 1998;199:358–65. - PubMed
    1. Prada AE, Zahedi K, Davis AE. Regulation of C`1-inhibitor synthesis. Immunobiology 1998;199:377–88. - PubMed
    1. Cullmen W, Opferkuck W. Deficiencies in regulator proteins l. C`-1 inhibitor. Progress in Allergy 1986;39:311–34. - PubMed
    1. Johnson AM, Alper CA, Rosen FS, et al. C`-1 inhibitor: evidence for decreased hepatic synthesis in hereditary angioedema. Science 1971;173:553–4. - PubMed
    1. Cicardi M, Bergamaschini L, Cugno M, et al. Pathogenic and clinical aspects of C`-1 inhibitor deficiency. Immunobiology 1998;199:366–76. - PubMed

Substances